Skip to content
Screener

Repligen RGEN Total Revenue

Total Revenue at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$11.99B
Danaher logo
DanaherDHR
$6.27B+5.5%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$65.84M+40.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$592.1M+1.1%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1B-2.7%
TEC
Bio-TechneTECH
$311.42M-1.5%

Segments

By product

See full
Proteins Products$97.44M+30.9%
Process Analytics Products$81.24M+37.0%
Royalty$43K+16.2%

Other financials

Income statement

See full
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$8.95B+42.1%
Enterprise value$9.03B+57.3%
P/E215.5×
P/S11.6×+0.3×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue:
Product$204,085$182,329$398,296$351,466
Royalty and other revenue43378772
Total revenue204,128182,366398,383351,538
Costs and operating expenses:
Cost of goods sold94,09189,371180,062167,172
Research and development14,41713,97028,87526,084
Selling, general and administrative76,61870,906153,154141,612

ITEM 1. Financial Statements

FAQ

What is Repligen's total revenue?
Repligen (RGEN) reported total revenue of $204.13M in Q2 2026.
How has Repligen's total revenue changed year-over-year?
Repligen's total revenue increased by 11.9% year-over-year, from $182.37M to $204.13M.
What is the long-term trend for Repligen's total revenue?
Over 2 years (2021 to 2023), Repligen's total revenue has grown at a -2.9% compound annual growth rate (CAGR), from $670.53M to $632.36M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Repligen's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude